Completed NA INTERVENTIONAL 3-arm NCT02739061

The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder

Shanghai Mental Health Center in China

Sponsor: Shanghai Mental Health Center

Conditions Obsessive-Compulsive Disorder

Interventions cognitive behavioral group therapy cognitive behavioral group therapy and drug therapy sertraline, fluvoxamine

Updated 7 times since 2017 Last updated: Jan 5, 2020 Started: Jun 12, 2014 Primary completion: Mar 8, 2017 Completion: Jul 24, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Obsessive-Compulsive Disorder, this trial is completed. The trial is conducted by Shanghai Mental Health Center and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2019 — Feb 2020 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jun 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Mental Health Center

Data source: Shanghai Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China